Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability Study of Amitriptyline Hydrochloride Tablets
NCT03646526Phase 1Completed
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Apr 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of amitriptyline in major depressive disorder (MDD) (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Maximum Plasma Concentration, Time to Maximum Plasma Concentration and 2 more. Started Apr 2018; status: completed.
02
Drugs
amitriptyline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03646526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03646526.